Pharma & Healthcare
Global 3D Printing Drug Market Research Report 2025
- Mar 11, 25
- ID: 31656
- Pages: 70
- Figures: 60
- Views: 19
The global market for 3D Printing Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
3D printing drugs can realize the advantages of precise control of drug dosage and precise control of release time, which has become one of the focuses of the pharmaceutical industry. The market potential is huge, so the number of companies entering the industry is increasing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
3D-printed drugs represent an innovative technology in the pharmaceutical manufacturing sector in recent years, enabling highly personalized medication through the application of 3D printing techniques. The market size has been progressively expanding, especially in the realms of specific patient populations and rare diseases, where the demand for tailored medications is on the rise. By employing 3D printing, drugs can achieve precise dosage and controlled release, thereby enhancing therapeutic efficacy. Looking ahead, as the technology matures further and regulations continue to evolve, 3D-printed drugs are poised to play a significant role in a broader spectrum of disease treatments.
This report aims to provide a comprehensive presentation of the global market for 3D Printing Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printing Drug.
The 3D Printing Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 3D Printing Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Printing Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Segment by Type
ZipDose
MED
FDM
SSE
Other
Segment by Application
Oral Solid Dosage Form
Non-Oral Solid Dosage Form
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3D Printing Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
3D printing drugs can realize the advantages of precise control of drug dosage and precise control of release time, which has become one of the focuses of the pharmaceutical industry. The market potential is huge, so the number of companies entering the industry is increasing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
3D-printed drugs represent an innovative technology in the pharmaceutical manufacturing sector in recent years, enabling highly personalized medication through the application of 3D printing techniques. The market size has been progressively expanding, especially in the realms of specific patient populations and rare diseases, where the demand for tailored medications is on the rise. By employing 3D printing, drugs can achieve precise dosage and controlled release, thereby enhancing therapeutic efficacy. Looking ahead, as the technology matures further and regulations continue to evolve, 3D-printed drugs are poised to play a significant role in a broader spectrum of disease treatments.
This report aims to provide a comprehensive presentation of the global market for 3D Printing Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printing Drug.
The 3D Printing Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 3D Printing Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Printing Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Segment by Type
ZipDose
MED
FDM
SSE
Other
Segment by Application
Oral Solid Dosage Form
Non-Oral Solid Dosage Form
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3D Printing Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 3D Printing Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ZipDose
1.2.3 MED
1.2.4 FDM
1.2.5 SSE
1.2.6 Other
1.3 Market by Application
1.3.1 Global 3D Printing Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Solid Dosage Form
1.3.3 Non-Oral Solid Dosage Form
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global 3D Printing Drug Market Perspective (2020-2031)
2.2 Global 3D Printing Drug Growth Trends by Region
2.2.1 Global 3D Printing Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 3D Printing Drug Historic Market Size by Region (2020-2025)
2.2.3 3D Printing Drug Forecasted Market Size by Region (2026-2031)
2.3 3D Printing Drug Market Dynamics
2.3.1 3D Printing Drug Industry Trends
2.3.2 3D Printing Drug Market Drivers
2.3.3 3D Printing Drug Market Challenges
2.3.4 3D Printing Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 3D Printing Drug Players by Revenue
3.1.1 Global Top 3D Printing Drug Players by Revenue (2020-2025)
3.1.2 Global 3D Printing Drug Revenue Market Share by Players (2020-2025)
3.2 Global 3D Printing Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by 3D Printing Drug Revenue
3.4 Global 3D Printing Drug Market Concentration Ratio
3.4.1 Global 3D Printing Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 3D Printing Drug Revenue in 2024
3.5 Global Key Players of 3D Printing Drug Head office and Area Served
3.6 Global Key Players of 3D Printing Drug, Product and Application
3.7 Global Key Players of 3D Printing Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 3D Printing Drug Breakdown Data by Type
4.1 Global 3D Printing Drug Historic Market Size by Type (2020-2025)
4.2 Global 3D Printing Drug Forecasted Market Size by Type (2026-2031)
5 3D Printing Drug Breakdown Data by Application
5.1 Global 3D Printing Drug Historic Market Size by Application (2020-2025)
5.2 Global 3D Printing Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America 3D Printing Drug Market Size (2020-2031)
6.2 North America 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America 3D Printing Drug Market Size by Country (2020-2025)
6.4 North America 3D Printing Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe 3D Printing Drug Market Size (2020-2031)
7.2 Europe 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe 3D Printing Drug Market Size by Country (2020-2025)
7.4 Europe 3D Printing Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 3D Printing Drug Market Size (2020-2031)
8.2 Asia-Pacific 3D Printing Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific 3D Printing Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific 3D Printing Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America 3D Printing Drug Market Size (2020-2031)
9.2 Latin America 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America 3D Printing Drug Market Size by Country (2020-2025)
9.4 Latin America 3D Printing Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 3D Printing Drug Market Size (2020-2031)
10.2 Middle East & Africa 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa 3D Printing Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa 3D Printing Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aprecia Pharmaceuticals
11.1.1 Aprecia Pharmaceuticals Company Details
11.1.2 Aprecia Pharmaceuticals Business Overview
11.1.3 Aprecia Pharmaceuticals 3D Printing Drug Introduction
11.1.4 Aprecia Pharmaceuticals Revenue in 3D Printing Drug Business (2020-2025)
11.1.5 Aprecia Pharmaceuticals Recent Development
11.2 Triastek
11.2.1 Triastek Company Details
11.2.2 Triastek Business Overview
11.2.3 Triastek 3D Printing Drug Introduction
11.2.4 Triastek Revenue in 3D Printing Drug Business (2020-2025)
11.2.5 Triastek Recent Development
11.3 FabRx
11.3.1 FabRx Company Details
11.3.2 FabRx Business Overview
11.3.3 FabRx 3D Printing Drug Introduction
11.3.4 FabRx Revenue in 3D Printing Drug Business (2020-2025)
11.3.5 FabRx Recent Development
11.4 Multiply Labs
11.4.1 Multiply Labs Company Details
11.4.2 Multiply Labs Business Overview
11.4.3 Multiply Labs 3D Printing Drug Introduction
11.4.4 Multiply Labs Revenue in 3D Printing Drug Business (2020-2025)
11.4.5 Multiply Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 3D Printing Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ZipDose
1.2.3 MED
1.2.4 FDM
1.2.5 SSE
1.2.6 Other
1.3 Market by Application
1.3.1 Global 3D Printing Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Solid Dosage Form
1.3.3 Non-Oral Solid Dosage Form
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global 3D Printing Drug Market Perspective (2020-2031)
2.2 Global 3D Printing Drug Growth Trends by Region
2.2.1 Global 3D Printing Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 3D Printing Drug Historic Market Size by Region (2020-2025)
2.2.3 3D Printing Drug Forecasted Market Size by Region (2026-2031)
2.3 3D Printing Drug Market Dynamics
2.3.1 3D Printing Drug Industry Trends
2.3.2 3D Printing Drug Market Drivers
2.3.3 3D Printing Drug Market Challenges
2.3.4 3D Printing Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 3D Printing Drug Players by Revenue
3.1.1 Global Top 3D Printing Drug Players by Revenue (2020-2025)
3.1.2 Global 3D Printing Drug Revenue Market Share by Players (2020-2025)
3.2 Global 3D Printing Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by 3D Printing Drug Revenue
3.4 Global 3D Printing Drug Market Concentration Ratio
3.4.1 Global 3D Printing Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 3D Printing Drug Revenue in 2024
3.5 Global Key Players of 3D Printing Drug Head office and Area Served
3.6 Global Key Players of 3D Printing Drug, Product and Application
3.7 Global Key Players of 3D Printing Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 3D Printing Drug Breakdown Data by Type
4.1 Global 3D Printing Drug Historic Market Size by Type (2020-2025)
4.2 Global 3D Printing Drug Forecasted Market Size by Type (2026-2031)
5 3D Printing Drug Breakdown Data by Application
5.1 Global 3D Printing Drug Historic Market Size by Application (2020-2025)
5.2 Global 3D Printing Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America 3D Printing Drug Market Size (2020-2031)
6.2 North America 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America 3D Printing Drug Market Size by Country (2020-2025)
6.4 North America 3D Printing Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe 3D Printing Drug Market Size (2020-2031)
7.2 Europe 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe 3D Printing Drug Market Size by Country (2020-2025)
7.4 Europe 3D Printing Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 3D Printing Drug Market Size (2020-2031)
8.2 Asia-Pacific 3D Printing Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific 3D Printing Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific 3D Printing Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America 3D Printing Drug Market Size (2020-2031)
9.2 Latin America 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America 3D Printing Drug Market Size by Country (2020-2025)
9.4 Latin America 3D Printing Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 3D Printing Drug Market Size (2020-2031)
10.2 Middle East & Africa 3D Printing Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa 3D Printing Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa 3D Printing Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aprecia Pharmaceuticals
11.1.1 Aprecia Pharmaceuticals Company Details
11.1.2 Aprecia Pharmaceuticals Business Overview
11.1.3 Aprecia Pharmaceuticals 3D Printing Drug Introduction
11.1.4 Aprecia Pharmaceuticals Revenue in 3D Printing Drug Business (2020-2025)
11.1.5 Aprecia Pharmaceuticals Recent Development
11.2 Triastek
11.2.1 Triastek Company Details
11.2.2 Triastek Business Overview
11.2.3 Triastek 3D Printing Drug Introduction
11.2.4 Triastek Revenue in 3D Printing Drug Business (2020-2025)
11.2.5 Triastek Recent Development
11.3 FabRx
11.3.1 FabRx Company Details
11.3.2 FabRx Business Overview
11.3.3 FabRx 3D Printing Drug Introduction
11.3.4 FabRx Revenue in 3D Printing Drug Business (2020-2025)
11.3.5 FabRx Recent Development
11.4 Multiply Labs
11.4.1 Multiply Labs Company Details
11.4.2 Multiply Labs Business Overview
11.4.3 Multiply Labs 3D Printing Drug Introduction
11.4.4 Multiply Labs Revenue in 3D Printing Drug Business (2020-2025)
11.4.5 Multiply Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global 3D Printing Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ZipDose
Table 3. Key Players of MED
Table 4. Key Players of FDM
Table 5. Key Players of SSE
Table 6. Key Players of Other
Table 7. Global 3D Printing Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global 3D Printing Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global 3D Printing Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global 3D Printing Drug Market Share by Region (2020-2025)
Table 11. Global 3D Printing Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global 3D Printing Drug Market Share by Region (2026-2031)
Table 13. 3D Printing Drug Market Trends
Table 14. 3D Printing Drug Market Drivers
Table 15. 3D Printing Drug Market Challenges
Table 16. 3D Printing Drug Market Restraints
Table 17. Global 3D Printing Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global 3D Printing Drug Market Share by Players (2020-2025)
Table 19. Global Top 3D Printing Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Drug as of 2024)
Table 20. Ranking of Global Top 3D Printing Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by 3D Printing Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of 3D Printing Drug, Headquarters and Area Served
Table 23. Global Key Players of 3D Printing Drug, Product and Application
Table 24. Global Key Players of 3D Printing Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global 3D Printing Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global 3D Printing Drug Revenue Market Share by Type (2020-2025)
Table 28. Global 3D Printing Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global 3D Printing Drug Revenue Market Share by Type (2026-2031)
Table 30. Global 3D Printing Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global 3D Printing Drug Revenue Market Share by Application (2020-2025)
Table 32. Global 3D Printing Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global 3D Printing Drug Revenue Market Share by Application (2026-2031)
Table 34. North America 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific 3D Printing Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific 3D Printing Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific 3D Printing Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. Aprecia Pharmaceuticals Company Details
Table 50. Aprecia Pharmaceuticals Business Overview
Table 51. Aprecia Pharmaceuticals 3D Printing Drug Product
Table 52. Aprecia Pharmaceuticals Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 53. Aprecia Pharmaceuticals Recent Development
Table 54. Triastek Company Details
Table 55. Triastek Business Overview
Table 56. Triastek 3D Printing Drug Product
Table 57. Triastek Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 58. Triastek Recent Development
Table 59. FabRx Company Details
Table 60. FabRx Business Overview
Table 61. FabRx 3D Printing Drug Product
Table 62. FabRx Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 63. FabRx Recent Development
Table 64. Multiply Labs Company Details
Table 65. Multiply Labs Business Overview
Table 66. Multiply Labs 3D Printing Drug Product
Table 67. Multiply Labs Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 68. Multiply Labs Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
Table 72. Authors List of This Report
List of Figures
Figure 1. 3D Printing Drug Picture
Figure 2. Global 3D Printing Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global 3D Printing Drug Market Share by Type: 2024 VS 2031
Figure 4. ZipDose Features
Figure 5. MED Features
Figure 6. FDM Features
Figure 7. SSE Features
Figure 8. Other Features
Figure 9. Global 3D Printing Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global 3D Printing Drug Market Share by Application: 2024 VS 2031
Figure 11. Oral Solid Dosage Form Case Studies
Figure 12. Non-Oral Solid Dosage Form Case Studies
Figure 13. Other Case Studies
Figure 14. 3D Printing Drug Report Years Considered
Figure 15. Global 3D Printing Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global 3D Printing Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global 3D Printing Drug Market Share by Region: 2024 VS 2031
Figure 18. Global 3D Printing Drug Market Share by Players in 2024
Figure 19. Global Top 3D Printing Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by 3D Printing Drug Revenue in 2024
Figure 21. North America 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America 3D Printing Drug Market Share by Country (2020-2031)
Figure 23. United States 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe 3D Printing Drug Market Share by Country (2020-2031)
Figure 27. Germany 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific 3D Printing Drug Market Share by Region (2020-2031)
Figure 35. China 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America 3D Printing Drug Market Share by Country (2020-2031)
Figure 43. Mexico 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa 3D Printing Drug Market Share by Country (2020-2031)
Figure 47. Turkey 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Aprecia Pharmaceuticals Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 51. Triastek Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 52. FabRx Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 53. Multiply Labs Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global 3D Printing Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ZipDose
Table 3. Key Players of MED
Table 4. Key Players of FDM
Table 5. Key Players of SSE
Table 6. Key Players of Other
Table 7. Global 3D Printing Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global 3D Printing Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global 3D Printing Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global 3D Printing Drug Market Share by Region (2020-2025)
Table 11. Global 3D Printing Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global 3D Printing Drug Market Share by Region (2026-2031)
Table 13. 3D Printing Drug Market Trends
Table 14. 3D Printing Drug Market Drivers
Table 15. 3D Printing Drug Market Challenges
Table 16. 3D Printing Drug Market Restraints
Table 17. Global 3D Printing Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global 3D Printing Drug Market Share by Players (2020-2025)
Table 19. Global Top 3D Printing Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Drug as of 2024)
Table 20. Ranking of Global Top 3D Printing Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by 3D Printing Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of 3D Printing Drug, Headquarters and Area Served
Table 23. Global Key Players of 3D Printing Drug, Product and Application
Table 24. Global Key Players of 3D Printing Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global 3D Printing Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global 3D Printing Drug Revenue Market Share by Type (2020-2025)
Table 28. Global 3D Printing Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global 3D Printing Drug Revenue Market Share by Type (2026-2031)
Table 30. Global 3D Printing Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global 3D Printing Drug Revenue Market Share by Application (2020-2025)
Table 32. Global 3D Printing Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global 3D Printing Drug Revenue Market Share by Application (2026-2031)
Table 34. North America 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific 3D Printing Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific 3D Printing Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific 3D Printing Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa 3D Printing Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa 3D Printing Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa 3D Printing Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. Aprecia Pharmaceuticals Company Details
Table 50. Aprecia Pharmaceuticals Business Overview
Table 51. Aprecia Pharmaceuticals 3D Printing Drug Product
Table 52. Aprecia Pharmaceuticals Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 53. Aprecia Pharmaceuticals Recent Development
Table 54. Triastek Company Details
Table 55. Triastek Business Overview
Table 56. Triastek 3D Printing Drug Product
Table 57. Triastek Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 58. Triastek Recent Development
Table 59. FabRx Company Details
Table 60. FabRx Business Overview
Table 61. FabRx 3D Printing Drug Product
Table 62. FabRx Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 63. FabRx Recent Development
Table 64. Multiply Labs Company Details
Table 65. Multiply Labs Business Overview
Table 66. Multiply Labs 3D Printing Drug Product
Table 67. Multiply Labs Revenue in 3D Printing Drug Business (2020-2025) & (US$ Million)
Table 68. Multiply Labs Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
Table 72. Authors List of This Report
List of Figures
Figure 1. 3D Printing Drug Picture
Figure 2. Global 3D Printing Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global 3D Printing Drug Market Share by Type: 2024 VS 2031
Figure 4. ZipDose Features
Figure 5. MED Features
Figure 6. FDM Features
Figure 7. SSE Features
Figure 8. Other Features
Figure 9. Global 3D Printing Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global 3D Printing Drug Market Share by Application: 2024 VS 2031
Figure 11. Oral Solid Dosage Form Case Studies
Figure 12. Non-Oral Solid Dosage Form Case Studies
Figure 13. Other Case Studies
Figure 14. 3D Printing Drug Report Years Considered
Figure 15. Global 3D Printing Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global 3D Printing Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global 3D Printing Drug Market Share by Region: 2024 VS 2031
Figure 18. Global 3D Printing Drug Market Share by Players in 2024
Figure 19. Global Top 3D Printing Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by 3D Printing Drug Revenue in 2024
Figure 21. North America 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America 3D Printing Drug Market Share by Country (2020-2031)
Figure 23. United States 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe 3D Printing Drug Market Share by Country (2020-2031)
Figure 27. Germany 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific 3D Printing Drug Market Share by Region (2020-2031)
Figure 35. China 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America 3D Printing Drug Market Share by Country (2020-2031)
Figure 43. Mexico 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa 3D Printing Drug Market Share by Country (2020-2031)
Figure 47. Turkey 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE 3D Printing Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Aprecia Pharmaceuticals Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 51. Triastek Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 52. FabRx Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 53. Multiply Labs Revenue Growth Rate in 3D Printing Drug Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232